{"id":252652,"date":"2012-05-23T15:10:40","date_gmt":"2012-05-23T15:10:40","guid":{"rendered":"http:\/\/www.eugenesis.com\/makucell-selected-as-a-%e2%80%9ccool-company%e2%80%9d-by-the-san-diego-venture-group\/"},"modified":"2012-05-23T15:10:40","modified_gmt":"2012-05-23T15:10:40","slug":"makucell-selected-as-a-cool-company-by-the-san-diego-venture-group","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/makucell-selected-as-a-cool-company-by-the-san-diego-venture-group.php","title":{"rendered":"Makucell Selected as a \u201cCool Company\u201d by the San Diego Venture Group"},"content":{"rendered":"<p><p>    SCOTTSDALE, Ariz. & SAN DIEGO--(BUSINESS    WIRE)--Makucell, Inc., a life science company    dedicated to the development, manufacture and distribution of    non-prescription products formulated to address the challenges    of aging and photo-damaged skin has been selected from 150    applicants as one of San Diego Venture Groups Cool Companies    to be showcased at the upcoming 10th Annual Venture    Summit on June 6, 2012. The selection criteria included    investor appeal, progress, and innovation. Makucell is one of    nine life science companies chosen.  <\/p>\n<p>      We are excited to have SDVGs vote of confidence and to      participate in this years venture summit    <\/p>\n<p>    We are excited to have SDVGs vote of confidence and to    participate in this years venture summit, commented Dr.    Lawrence Rheins, President and CEO of Makucell. Makucells    Renewnt products are at the forefront of skin science; the    clinical tests prove their efficacy and safety. The Makucell    team is confident that we have a superior product, winning    solution and without question, a very cool company.  <\/p>\n<p>    Michael Kahn, Ph.D., Makucell Co-founder, Board Chairman and    distinguished research scientist at the Eli and Edythe Broad    Center for Regenerative Medicine and Stem Cell Research of the    Keck School of Medicine at the University of Southern    California, added, Renewnts proprietary ingredient,    Asymmtate, is a novel approach to cellular aging, working with    the bodys own skin stem cells by optimizing the signals in the    Wnt (pronounced wint) pathway to encourage production of the    components that create the skins supportive matrix. This    essential regenerative process is the key differentiator in    Makucells Renewnt products.  <\/p>\n<p>    Dr. Mark V. Dahl, Makucell Chief Medical Officer and former    President of the American Academy of Dermatology, developed the    formulations. Each product targets a specific area of the body    with ingredients in specific proportions most suited for that    type of skin, explained Dr. Dahl. And all Renewnt products    are formulated to reduce the appearance of fine lines,    wrinkles, roughness, thinning skin and pigment irregularities.  <\/p>\n<p>    Initially, Makucell is offering Renewnt products exclusively    through aesthetic skincare professionals and directly via our    toll-free number (1-855-MAKUCLL).  <\/p>\n<p>    About Makucell  <\/p>\n<p>    Makucell Inc. (www.Makucell.com)    is a life science company dedicated to the development,    manufacture and distribution of non-prescription topical    products developed to address the challenges of aging and    photo-damaged skin. Based on scientific research at the Broad    Center for Regenerative Medicine and Stem Cell Research at the    Keck School of Medicine of USC, Makucells Renewnt products    are formulated to enhance theskin's appearance, making it    stronger and more youthful-looking. The companys new    proprietary technology, Asymmtate, works with an individuals    own skin stem cells to maintain cellular differentiation which    decreases as we age.  <\/p>\n<p>    The San Diego Venture Group  <\/p>\n<p>    The San Diego Venture Group cultivates durable and high value    relationships between entrepreneurs, capital providers and    strategic advisors intended to promote the formulation and    funding of innovative new ventures in the San Diego area    community.     <a href=\"http:\/\/www.sdvg.org\" rel=\"nofollow\">http:\/\/www.sdvg.org<\/a>.  <\/p>\n<\/p>\n<p>Original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.businesswire.com\/news\/home\/20120522006913\/en\/Makucell-Selected-\u201cCool-Company\u201d-San-Diego-Venture\" title=\"Makucell Selected as a \u201cCool Company\u201d by the San Diego Venture Group\">Makucell Selected as a \u201cCool Company\u201d by the San Diego Venture Group<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SCOTTSDALE, Ariz. &#038; SAN DIEGO--(BUSINESS WIRE)--Makucell, Inc., a life science company dedicated to the development, manufacture and distribution of non-prescription products formulated to address the challenges of aging and photo-damaged skin has been selected from 150 applicants as one of San Diego Venture Groups Cool Companies to be showcased at the upcoming 10th Annual Venture Summit on June 6, 2012 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/makucell-selected-as-a-cool-company-by-the-san-diego-venture-group.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577503],"tags":[],"class_list":["post-252652","post","type-post","status-publish","format-standard","hentry","category-anti-aging-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/252652"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=252652"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/252652\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=252652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=252652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=252652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}